The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Drug delivery vehicles on a nano-engineering perspective
Open accessAbstract
Nanoengineered drug delivery systems (nDDS) have been successfully used as clinical tools for not only modulation of pharmacological drug release profile but also specific targeting of diseased tissues. Until now, encapsulation of anti-cancer molecules such as paclitaxel, vincristin and doxorubicin has been the main target of nDDS, whereby liposomes and polymer-drug conjugates remained as the most popular group of nDDS used for this purpose. The success reached by these nanocarriers can be imitated by careful selection and optimization of the different factors that affect drug release profile (i.e. type of biomaterial, size, system architecture, and biodegradability mechanisms) along with the selection of an appropriate manufacture technique that does not compromise the desired release profile, while it also offers possibilities to scale up for future industrialization. This review focuses from an engineering perspective on the different parameters that should be considered before and during the design of new nDDS, and the different manufacturing techniques available, in such a way to ensure success in clinical application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–218 of 218
Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer
Julien, D. C., Behnke, S., Wang, G., Murdoch, G. K., & Hill, R. A. (2011) · mAbs · doi:10.4161/mabs.3.5.16089 · Cited by 44
Liposomes for Protein Delivery: Selecting Manufacture and Development Processes
Weiner, A. L. (1994) · ImmunoMethods · doi:10.1006/immu.1994.1021 · Cited by 44
Cho, E. C., Lim, H. J., Kim, H. J., Son, E. D., Choi, H. J., Park, J. H., Kim, J., & Kim, J. (2008) · Materials Science and Engineering C · doi:10.1016/j.msec.2008.07.014 · Cited by 42
Histone deacetylase inhibitors: a patent review (2009 – 2011)
Carafa, V., Miceli, M., Altucci, L., & Nebbioso, A. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.736493 · Cited by 42
Jäger, E., Jäger, A., Etrych, T., Giacomelli, F. C., Chytil, P., Jigounov, A., Putaux, J., Řı́hová, B., Ulbrich, K., & Štěpánek, P. (2012) · Soft Matter · doi:10.1039/c2sm26150b · Cited by 39
Specific features of drug encapsulation in liposomes (A review)
Владимировна, Т. Е., Kostin, K. V., & Оборотова, Н. А. (2011) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-011-0661-4 · Cited by 38
Folkman, J. (1990) · Biomaterials · doi:10.1016/0142-9612(90)90017-k · Cited by 36
Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug
Boehlke, L., & Winter, J. N. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.4.409 · Cited by 35
Comparative study of paclitaxel physically encapsulated in and chemically conjugated with PEG‐PLA
Xu, X., Zhang, X., Wang, X., Li, Y., & Jing, X. (2008) · Polymers for Advanced Technologies · doi:10.1002/pat.1341 · Cited by 32
“Smart” liposomal nanocontainers in biology and medicine
Tarahovsky, Y. S. (2010) · Biochemistry (Moscow) · doi:10.1134/s0006297910070023 · Cited by 30
Stability of Uni‐ and Multillamellar Spherical Vesicles
Tayebi, L., Vashaee, D., & Parikh, A. N. (2011) · ChemPhysChem · doi:10.1002/cphc.201100573 · Cited by 29
Froudarakis, Μ. E., Pataka, A., Pappas, P., Anevlavis, S., Argiana, E., Nikolaidou, M., Kouliatis, G., Pozova, S., Μαρσέλος, Μ., & Bouros, D. E. (2008) · Cancer · doi:10.1002/cncr.23921 · Cited by 25
Poly lactic acid (PLA) nanoparticles sustain the cytotoxic action of temozolomide in C6 Glioma cells
Jain, D. S., Athawale, R., Bajaj, A. N., et al. (2013) · Biomedicine & Aging Pathology · doi:10.1016/j.biomag.2013.08.003 · Cited by 24
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myeloma
Pratt, G., Wiles, M. E., Rawstron, A. C., Davies, F. E., Fenton, J. A. L., Proffitt, J. A., Child, J. A., Smith, G., & Morgan, G. J. (1998) · Hematological Oncology · doi:10.1002/(sici)1099-1069(199806)16:2<47::aid-hon622>3.0.co;2-3 · Cited by 23
The aetiology of periductal mastitis
Bundred, N. J. (1993) · The Breast · doi:10.1016/0960-9776(93)90027-d · Cited by 16
Copolymers for Hepatocyte‐Specific Targeting Carrying Galactose and Hydrophobic Alkyl Groups
Hiratsuka, T., Goto, M., Kondo, Y., Cho, C., & Akaike, T. (2007) · Macromolecular Bioscience · doi:10.1002/mabi.200700157 · Cited by 15
Influence of lipopolymer concentration on liposome degradation and blood clearance
Vermehren, C., Jørgensen, K., & Frøkjær, S. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00051-4 · Cited by 12
Sucrose-Formulated Octocog Alfa
Frampton, J. E., & Wagstaff, A. J. (2008) · Drugs · doi:10.2165/00003495-200868060-00007 · Cited by 8
Cited by
Liposomes as nanomedical devices
Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,261
Chandrakala, V., Aruna, V., & Angajala, G. (2022) · Emergent Materials · doi:10.1007/s42247-021-00335-x · Cited by 768
Antitumor Activities of Metal Oxide Nanoparticles
Vinardell, M., & Mitjans, M. (2015) · Nanomaterials · doi:10.3390/nano5021004 · Cited by 337
Nanoscale Self-Assembly for Therapeutic Delivery
Yadav, S., Sharma, A. K., & Kumar, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00127 · Cited by 324
Nanoscale Drug Delivery Systems: From Medicine to Agriculture
Vega-Vásquez, P., Mosier, N. S., & Irudayaraj, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00079 · Cited by 323
Metadata
- Authors
- Felice, B., Prabhakaran, M. P., Rodríguez, A. P., & Ramakrishna, S.
- Venue
- Materials Science and Engineering: C
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 41
- Pages
- 178-195
- ISSN
- 0928-4931 (ISSN-L)
- OpenAlex
- W2078446103
- Cited by
- 253
- References
- 218
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.